Browsing Tag
CGT exclusivity
1 post
Lupin (NSE: LUPIN) secures CGT exclusivity for Risperidone LAI, launches first PrecisionSphere injectable in U.S.
Lupin Limited launches Risperidone injectable in the U.S. with 180-day CGT exclusivity, marking its entry into long-acting injectables via PrecisionSphere.